Notice of interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 16.8.2022Teva B.V. (TEV-NL-4)28620Hylak forte (gto por 1x100 ml (liek.skl.hnedá))16.8.2022R
 16.8.2022Teva B.V. (TEV-NL-4)28619Hylak forte (gto por 1x30 ml (liek.skl.hnedá))16.8.2022R
 16.8.2022N.V. Organon (ORG-NL)13175Maxalt RPD 10 mg (lyo por 6x10 mg (blis.PVC/PVDC/Al))16.8.2022R
 16.8.2022Mylan Pharmaceuticals Limited (MLB-IE-1)6935BCinacalcet Mylan 60 mg filmom obalené tablety (tbl flm 28x60 mg (blis.Al/PVDC/PVC))17.8.2022R
 16.8.2022Mylan Ireland Limited (MNY)53741Betahistin Mylan 24 mg (tbl 50x24 mg (blis.PVC/PVDC/Al))17.8.2022R
 16.8.2022Merck Sharp & Dohme B.V. (MSD-NL)35586RotaTeq perorálny roztok (sol por 1x2 ml (tuba LDPE))22.8.2022R
 16.8.2022Janssen - Cilag International N.V. (JNS)2189BIMBRUVICA 140 mg tvrdé kapsuly (cps dur 90x140 mg (fľ. HDPE))31.8.2022Z
 16.8.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)92310DHC Continus 60 mg (tbl mod 60x60 mg (blis.PVC/Al))16.8.2022R
 16.8.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)22813Targin 10/5 mg tablety s predĺženým uvoľňovaním (tbl plg 60x10 mg/5 mg (blis.PVC/Al))16.8.2022R
 16.8.2022Instituto Grifols, S.A. (GFO)45084Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x400 ml/20 g (liek.skl.))16.8.2022R
 16.8.2022Instituto Grifols, S.A. (GFO)45083Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x200 ml/10 g (liek.skl.))16.8.2022R
 15.8.2022Zentiva a.s. (ZNT-SK-2)00720KANAVIT (gte por 1x5 ml/100 mg (fľ.skl.hnedá))16.8.2022O
 15.8.2022Novartis Europharm Limited (NEH-IE)2593BNEVANAC 3 mg/ml, očná suspenzná instilácia (int opu 1x3 ml/9 mg (fľ. LDPE-oválna))22.8.2022R
 15.8.2022Novartis Slovakia s.r.o. (NVL-2)57866TOBRADEX (int opu 1x5 ml (fľ.PE))17.8.2022R
 15.8.2022Novartis Slovakia s.r.o. (NVL-2)2854CMiflonide Breezhaler 400 (plv icd 60(6x10)x400 µg (blis.PVC/PVDC/Al+ 1 inhalátor Breezhaler))17.8.2022R

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To